[HTML][HTML] Apoptosis deregulation and the development of cancer multi-drug resistance
Simple Summary Despite recent therapeutic advances against cancer, many patients do not
respond well or respond poorly, to treatment and develop resistance to more than one anti …
respond well or respond poorly, to treatment and develop resistance to more than one anti …
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.
CM Neophytou, IP Trougakos, N Erin, P Papageorgis - Cancers, 2021 - europepmc.org
The ability of tumor cells to evade apoptosis is established as one of the hallmarks of cancer.
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
[PDF][PDF] Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers 2021, 13, 4363
CM Neophytou, IP Trougakos, N Erin, P Papageorgis - 2021 - pdfs.semanticscholar.org
The ability of tumor cells to evade apoptosis is established as one of the hallmarks of cancer.
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
[HTML][HTML] Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
CM Neophytou, IP Trougakos, N Erin, P Papageorgis - Cancers, 2021 - ncbi.nlm.nih.gov
The ability of tumor cells to evade apoptosis is established as one of the hallmarks of cancer.
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.
CM Neophytou, IP Trougakos, N Erin… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Despite recent therapeutic advances against cancer, many
patients do not respond well or respond poorly, to treatment and develop resistance to more …
patients do not respond well or respond poorly, to treatment and develop resistance to more …
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
CM Neophytou, IP Trougakos, N Erin… - …, 2021 - pubmed.ncbi.nlm.nih.gov
The ability of tumor cells to evade apoptosis is established as one of the hallmarks of cancer.
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
CM Neophytou, IP Trougakos, N Erin… - Cancers, 2021 - search.proquest.com
The ability of tumor cells to evade apoptosis is established as one of the hallmarks of cancer.
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
C Neophytou, I Trougakos, N ERİN… - CANCERS, 2021 - avesis.akdeniz.edu.tr
Simple Summary Despite recent therapeutic advances against cancer, many patients do not
respond well or respond poorly, to treatment and develop resistance to more than one anti …
respond well or respond poorly, to treatment and develop resistance to more than one anti …
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.
CM Neophytou, IP Trougakos, N Erin, P Papageorgis - Cancers, 2021 - europepmc.org
The ability of tumor cells to evade apoptosis is established as one of the hallmarks of cancer.
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …
The deregulation of apoptotic pathways conveys a survival advantage enabling cancer cells …